Methylnaltrexone bromide enteric-coated (Norgine)

溴化甲基纳曲酮肠溶片(Norgine)

Report date: 2025/08/14 14:05:33

Base Information

Drug NameMethylnaltrexone bromide enteric-coated (Norgine)
Drug Alias NameEnteric-coated methylnaltrexone bromide (Norgine)NRL-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMu opioid receptor antagonists
TargetsMu opioid receptor
Therapy Area/IndicationsConstipation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorgine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorgine
Active IndicationsN/A
Inactive IndicationsConstipation

Other Information

ATC CodeN/A
Related LinksN/A